Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

Tumor formation in p53 mutant ovaries transplanted into wild-type female hosts

Abstract

p53 gene alterations correlate highly with advanced ovarian carcinoma in women. In mice, p53 deficiency predominantly results in the formation of lymphomas and sarcomas. However, ovarian epithelial tumors have not been documented in p53 homozygous mutant (p53−/−) mice, probably because they die before other tumors can form. To determine whether p53−/− ovaries can develop epithelial tumors, they were transplanted into the ovarian bursae of histocompatible wild-type recipient females. The p53−/− ovarian grafts formed tumors 1 year post-transplantation. The tumor type was angiosarcoma, suggesting that vascular tissues are predisposed to tumor formation in p53−/−ovaries. These findings suggest that p53 deficiency alone is not sufficient for ovarian epithelial tumorigenesis in mice. Thus, other genetic lesions are likely required to develop mouse models of human ovarian cancer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Auersperg N, Wong AS, Choi KC, Kang SK and Leung PC . (2001). Endocr. Rev., 22, 255–288.

  • Bast Jr RC and Mills GB . (2000). Ovarian Cancer: Methods and Protocols Bartlett JMS (ed). Humana Press: New Jersey, pp. 37–48.

    Book  Google Scholar 

  • Blackburn AC, Brown JS, Naber SP, Otis CN, Wood JT and Jerry DJ . (2003). Cancer Res., 63, 2364–2368.

  • Chen CM and Behringer RR . (2004). Genes Dev., 18, 320–332.

  • Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery Jr CA, Butel JS and Bradley A . (1992). Nature, 356, 215–221.

  • Flesken-Nikitin A, Choi KC, Eng JP, Shmidt EN and Nikitin AY . (2003). Cancer Res., 63, 3459–3463.

  • Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT and Weinberg RA . (1994). Curr. Biol., 4, 1–7.

  • Jemal A, Murray T, Samuels A, Ghafoor A, Ward E and Thun MJ . (2003). CA Cancer J. Clin., 53, 5–26.

  • Jylling AM, Jorgensen L and Holund B . (1999). Pathol. Oncol. Res., 5, 318–319.

  • Kuperwasser C, Hurlbut GD, Kittrell FS, Dickinson ES, Laucirica R, Medina D, Naber SP and Jerry DJ . (2000). Am. J. Pathol., 157, 2151–2159.

  • Mohr U (ed). (2001). International Classification of Rodent Tumors: The Mouse. Springer-Verlag: Berlin.

    Book  Google Scholar 

  • Nagy A, Gertsenstein M, Vintersten K and Behringer RR (eds). (2003). Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor Laboratory Press: New York.

    Google Scholar 

  • Naka N, Tomita Y, Nakanishi H, Araki N, Hongyo T, Ochi T and Aozasa K . (1997). Int. J. Cancer, 71, 952–955.

  • Nucci MR, Krausz T, Lifschitz-Mercer B, Chan JK and Fletcher CD . (1998). Am. J. Surg. Pathol., 22, 620–630.

  • Orsulic S, Li Y, Soslow RA, Vitale-Cross LA, Gutkind JS and Varmus HE . (2002). Cancer Cell, 1, 53–62.

  • Platt JS, Rogers SJ, Flynn EA and Taylor RR . (1999). Gynecol. Oncol., 73, 443–446.

  • Purdie CA, Harrison DJ, Peter A, Dobbie L, White S, Howie SE, Salter DM, Bird CC, Wyllie AH, Hooper ML and Clarke AR . (1994). Oncogene, 9, 603–609.

  • Schuijer M and Berns EMJJ . (2003). Hum. Mutat., 21, 285–291.

  • Shelling AN, Cooke IE and Ganesan TS . (1995). Br. J. Cancer, 72, 521–527.

  • Turusov VS and Mohr U (eds). (1994). Pathology of Tumours in Laboratory Animals. Vol II – Tumours of the Mouse 2nd edn, IARC Scientific Publications no. 111. International Agency for Research on Cancer: Lyon, France.

    Google Scholar 

  • Venkatachalam S, Tyner S and Donehower LA . (2002). Tumor Models in Cancer Research Teicher BA (ed). Humana Press: New Jersey, pp. 247–261.

    Google Scholar 

  • Zietz C, Rössle M, Haas C, Sendelhofert A, Hirschmann A, Stürzl M and Löhrs U . (1998). Am. J. Pathol., 153, 1425–1433.

Download references

Acknowledgements

This work was supported by a Development Grant from the National Cancer Institute Specialized Programs of Research Excellence in Ovarian Cancer (CA83639) and grants from the National Institutes of Health (NIH) (HD30284) and Department of Defense Ovarian Cancer Research Program (OC020187) to RRB. Veterinary resources were supported by the NIH Cancer Center Support (Core) Grant CA16672.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Richard R Behringer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, CM., Chang, JL. & Behringer, R. Tumor formation in p53 mutant ovaries transplanted into wild-type female hosts. Oncogene 23, 7722–7725 (2004). https://doi.org/10.1038/sj.onc.1208037

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208037

Keywords

This article is cited by

Search

Quick links